Neuronetics Announces Strategic Leadership Promotions to Support Future Growth
February 11, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NeuroStar® Advanced Therapy’s Depression Outcomes Registry Hits 10,000 Patient Milestone
January 19, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners
December 08, 2020 16:05 ET
|
Neuronetics
MALVERN, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol
November 23, 2020 16:05 ET
|
Neuronetics
MALVERN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
November 02, 2020 16:05 ET
|
Neuronetics
MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Journal of Affective Disorders Publishes Clinical Data Suggesting NeuroStar® Advanced Therapy as a First-line Treatment for Major Depressive Disorder
October 13, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month
October 01, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS
September 29, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Unveils New Depression Data at Clinical TMS Society’s Virtual Events
September 22, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Second Quarter 2020 Financial and Operating Results
August 04, 2020 07:30 ET
|
Neuronetics
MALVERN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...